Abstract
Summary The Oropouche virus, initially detected in Trinidad and Tobago in 1955, has been historically confined to the Amazon Basin. However, since late 2022, it has been reported elsewhere, from northern Brazil to urban centers in Bolivia, Colombia, Cuba, and Peru. In this report we describe the doubling of publicly available full genomes by generating 133 new entries. We show how the virus evolved via recombination and how it rapidly spread across multiple states in Brazil, causing the largest outbreak ever recorded outside the Amazon basin including the first ever detected deaths. This work highlights the need for heightened epidemiological and genomic surveillance and the implementation of adequate responses in order to avoid Oropouche becoming another widespread arboviral public health threat.
Background The Oropouche virus was first identified in 1955 in Trinidad and Tobago and later found in Brazil in 1960. Historically, it has been reported to have caused around 30 outbreaks, most of which within the Amazon Basin where it circulates among forest animals, but also in urban areas where it is known to be transmitted by the midge Culicoides paraensis. Recently, Brazil has seen a surge in cases, with 6000 reported by mid-2024 alone.
Methods In a collaboration with Central Public Health Laboratories across Brazilian regions, we integrated epidemiological metadata with genomic analyses of recently sampled cases. This initiative resulted in the generation of 133 whole genome sequences from the three genomic segments (L, M, and S) of the virus, including the first genomes obtained from regions outside the Amazon and from the first ever recorded fatal cases.
Findings All of the 2024 genomes form a monophyletic clade in the phylogenetic tree with sequences from the Amazon Basin sampled since 2022. Our analyses reveal a fast and clear pattern of north-to-south viral movement from the Amazon Basin into historically non-endemic regions. We identified 21 recombinant events, but it remains unclear if such genomic changes mirror potential adaptations and the emergence of new viral phenotypes of public health importance.
Interpretation Both the recent rapid spatial expansion and the first reported fatalities associated with Oropouche underscore the importance of enhancing surveillance at both national and continental levels. Without any obvious changes in the human population over the past 2 years, it remains likely that either alone or in combination, viral adaptation, deforestation and climate change trends in the recent past may have propelled the Oropouche virus beyond the Amazon Basin.
Evidence before this study Before this study, the Oropouche virus was known to cause periodic outbreaks primarily within the Amazon Basin. Initially identified in Trinidad and Tobago in 1955, the virus had been responsible for approximately 30 outbreaks in Latin America, mostly confined to the Amazon region. The virus typically circulates among forest animals and is transmitted to humans by the bite of the midge Culicoides paraensis. There has been an historical dearth of available genomic data, and so far the spread beyond the Amazon Basin has not been well-documented.
Added value of this study This study provides a timely and comprehensive analysis of epidemiological and genomic data of the Oropouche virus from regions outside the Amazon Basin. By generating 133 whole genome sequences from various regions across Brazil, the study doubles the number of publicly available genomes. Our findings reveal the virus’ movement over the past few years across Brazil, highlighting a north-south spatial trend from regions of historic endemicity to regions with clear epidemic potential. We identify 21 recombinant events, of which the potential for adaptation and the emergence of novel viral phenotypes remains possible but unclear. This study also reports the first fatal cases of Oropouche virus infection in patients without underlying relevant comorbidities, underscoring the public health risk of future outbreaks and the need for increased awareness and surveillance.
Implications of all the available evidence The rapid spread of the Oropouche virus beyond the Amazon Basin into regions of Brazil further away than 3500 Km, coupled with the identification of genome recombinant events, raises the possibility that the virus is adapting to the new environments of its increasing spatial landscape. This evolution could lead to the emergence of new viral phenotypes, with potential changes at various levels, from vector efficiency, to disease outcome, raising the challenge of managing future outbreaks. The evidence underscores the critical need for enhanced surveillance systems at national and continental levels, in particular in urban centers which appear to have been particularly hit during the spatial expansion, to detect and respond to Oropouche virus outbreaks promptly.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by the National Institutes of Health USA grant U01 AI151698 for the United World Arbovirus Research Network (UWARN), the CRP ICGEB RESEARCH GRANT 2020 Project CRP/BRA20-03, Contract CRP/20/03, and the Rede Unificada de Analises Integradas de Arbovirus de Minas Gerais (REDE UAI ARBOMG), financed by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), grant number RED0023423. M. Giovanetti's funding is provided by PON "Ricerca e Innovazione'' 2014, 2020. T.E.R.A. is supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) under the process number 153597/2024-0. F.C.M.I. is supported by FAPEMIG under process number BIP-00123-23. The authors would also like to acknowledge the Global Consortium to Identify and Control Epidemics CLIMADE (https://climade.health/).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This project was reviewed and approved by the Ethical Committee of the Federal University of Minas Gerais (CAAE: 32912820.6.1001.5149). The availability of the samples for research purposes during outbreaks of national concern is allowed by the terms of the 510/2016 Resolution of the National Ethical Committee for Research (CONEP - Comissao Nacional de Etica em Pesquisa, Ministerio da Saude) of the Brazilian Ministry of Health (BrMoH), that authorize, without the necessity of an informed consent, the use of clinical samples collected in the Brazilian Central Public Health Laboratories to accelerate knowledge building and contribute to surveillance and outbreak response. The samples processed in this study were obtained anonymously from material collected during routine arboviral diagnosis in Brazilian public health laboratories within the BrMoH network.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
NA
